UX/UI Design Co-Op

Developing a frictionless robotic surgical system that provides medical professionals confidence in navigating the future of soft tissue robotic surgery.

Overview

During 2023, I had the amazing opportunity to spend 6 months with J&J in the Santa Clara office. As a UX/UI Design Co-Op for the OTTAVA robotic surgical system, I worked on everything from cross-functional stakeholder collaboration, user research/testing, design systems, and developing prototypes with multiple prototyping tools. Working alongside a team of talented designers, researchers, engineers, Project Managers, and surgeons throughout this experience helping cultivate my skills and knowledge as a UX Designer.

The OTTAVA™ System is designed to transform the surgical experience with innovative architecture, clinically relevant features, and trusted Ethicon instrumentation; Johnson & Johnson MedTech anticipates 2024 FDA Submission to Initiate U.S. Clinical Trials

Role

UX/UI Designer

Intern/Co-Op President

Skills

Product Design

Advanced Prototyping

Design Systems

Cross-functional

collaboration

Team

OTTAVA™ HFXD Team

UX/Industrial Design

Human Factors Engineers

Clinical Engineers

GUI Developers

In-House Surgeons

Timeline

6 months, 2023

Please contact me for more information about this Co-Op Project Experience!

* Project Under NDA *

Targeting the second half of 2024 to submit the OTTAVA™ robotic surgical system. An IDE(investigational device exemption) application will be submitted to the U.S. FDA in order to initiate clinical trials.

How might the OTTAVA™ System reimagine the future of surgical experiences for surgeons, operating room staff, and patients?

— Key Learnings

Developed MVP's, Design System, Conducted User Interviews/Testing and collaborated with a cross functional team of stakeholders in an accelerated 6 month Co-Op.

Creating impact through...

— Contextualizing

Collaboration with stakeholders on aligning business goals with user needs, and contextualizing through working with equipment and workflows.

A huge shoutout to the wonderful folks at J&J for taking good care of me during my time on the team!

— Company Updates/Releases

Nov. 7, 2023 – New Brunswick, New Jersey – Johnson & Johnson MedTech* today announced plans to submit the OTTAVA robotic surgical system for an investigational device exemption (IDE) application to the U.S. Food & Drug Administration (FDA) in the second half of 2024 to initiate clinical trials. Drawing on Johnson & Johnson MedTech’s more than 135-year legacy of leadership in surgery, OTTAVA reimagines the surgical experience. The system is designed to create space in the operating room (OR), simplify complex workflows, enable flexibility for clinical approaches, and deliver the trusted performance of Ethicon** instrumentation.